Mark Moody, Ph.D. of Activate will present at the STING&TLR-Targeting Therapies conference

Mark Moody, Ph.D. of Activate will present “Nanomedicine Formulations for Delivery of TLR Agonist Drug Combinations” at the May 9-11 STING&TLR-Targeting Therapies conference in Boston.